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1. Introduction 
HIV infection is associated with a progressive loss of CD4+ T cells, leading to an acquired 
immunodeficiency syndrome (AIDS). The CD4+ T-cell depletion is due to the direct 
destruction of infected CD4+ T cells, as well as to an impaired production of T cells in the 
thymus. Our understanding of the exact role of the thymus in HIV-1 infection and HIV-1 
pathogenesis remains incomplete, although substantial progress has been made over the last 
decade. De Novo generation of naïve human T cells occurs in the thymus, seeded with 
CD34+ progenitor cells, migrating from the bone marrow. These progenitor cells 
sequentially undergo a process of tightly controlled differentiation, including the 
rearrangement of T cell receptor genes, ultimately leading to the generation of functionally 
mature CD4+ and CD8+ single-positive (SP) T cells. Much has been learned of the types of 
cells in the thymus that are targets for CXCR4-tropic and CCR5-tropic HIV-1 isolates. 
Several groups provided evidence that HIV can infect thymocytes at various developmental 
stages. In addition, HIV activates the natural type-I-interferon (IFN)-producing 
plasmacytoid dendritic cells (pDC) that may induce bystander effects resulting in chronic 
immune activation. Evidence is also mounting that HIV induces abnormal development of 
regulatory T (Treg) cells in the thymus, either by direct infection or by enhancement of their 
survival and function, mediated by host-derived pro-inflammatory molecules. Collectively, 
these events compromise thymic function resulting in a decreased thymic output and a 
general decline in peripheral CD4+ T-cell numbers. Here we aim to discuss the cellular 
targets for CCR5-tropic and CXCR4-tropic HIV-1 isolates in the thymus, and how virus 
tropism relates to architectural differences observed in the HIV-infected thymus. In 
addition, we will discuss the role of pDC and Treg in HIV pathogenicity, and the impact of 
type I IFN on T cell regeneration. Finally, we will review the present status on the use of 
humanized mouse and non-human primate models to study HIV-1 infection of the thymus. 
2. Thymic seeding progenitor cells 
T cells uniquely complete their development in the specialized environment of the thymus, 
which in addition to TCR T cells also supports development of functionally different 
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types of T cells, including TCR T cells, NKT cells, and regulatory T cells. The human 
thymus is seeded by hematopoietic progenitor cells that arrive via the blood and initially 
originate from the fetal liver (between week 6-20 of gestation) and later from the fetal bone 
marrow (from week 20 of gestation) and adult bone marrow. Our current understanding is 
that the thymus remains active through an advanced age, suggesting that thymic seeding 
progenitor cells (TSPs) should be present in adult blood. It is well established that all 
hematopoietic precursors in humans are present within a population of cells that express 
CD34 (Payne & Crooks, 2002), and this marker is useful in elucidating pathways in the 
development of particular hematopoietic lineages. In umbilical cord blood (UCB), 
CD34+CD45RA+CD7+ cells are found to have T, B, and NK and some granulocyte-
macrophage (GM) precursor activities (Haddad et al., 2004; Hao et al., 2001). Phenotypically 
these cells resemble the CD34+CD38low Early Thymic Progenitor cells (ETP), which are 
present within the thymus and have T cell, NK cell, and Dendritic Cell (DC) precursor 
activities (Res et al., 1996). The ETP have not yet undergone T cell receptor (TCR) gene 
rearrangements confirming that they form the most immature population in the thymus 
(Dik et al., 2005). This, together with the observation that ETP co-express CD10, makes it 
tempting to speculate that they are the direct progeny of the 
CD34+CD45RA+CD7+CD10+CD38low UCB cells (Hao et al., 2001). In addition, the notion that 
the human thymus harbors multipotential precursors indicates that T cell commitment takes 
place within this organ (Bhandoola et al., 2003). While these results are in line with data 
obtained in the mouse, more recent studies suggested that the murine thymus can be seeded 
not only by multipotent precursors, but also by precursor cells that are lineage restricted 
(Petrie & Kincade, 2005; Porritt et al., 2004). If that would be the case in humans, such 
lineage restricted cells should be present in UCB, but conflicting results were reported on 
this issue. One study failed to find evidence for the presence of TCR rearrangements in UCB 
CD34+ cells (Blom et al., 1997), but another study reported the presence of complete TCRǅ 
and partial TCRǃ (Dǃ-Jǃ) rearrangements in CD34+CD7+ cord blood precursors (Ktorza et 
al., 1996). It is obvious that re-analysis preferentially by single-cell PCR analysis of the 
recently identified rare CD34+CD45RA+CD7+ UCB population is required to solve this issue 
(Haddad et al., 2004; Hao et al., 2001). T cell–restricted precursors were convincingly 
identified in human bone marrow (Klein et al., 2003a), but whether these cells can migrate to 
the thymus is unclear. In the mouse it was demonstrated that for the proper seeding of 
progenitor cells into the thymus the collective action of the chemokine receptors CCR7 and 
CCR9 is required (Zlotoff et al., 2010). The role of these chemokine receptors to direct 
human progenitor cells into the thymus has not been established. In summary, at least a 
proportion of the precursors that seed the human thymus are multipotent. It remains elusive 
whether or not some of the precursors that migrate into the thymus are lineage restricted 
before entrance, and which signals control their thymic seeding. 
3. Cellular stages in the development of early thymic progenitor cells into 
mature T Cells 
In the thymus different regions can be distinguished, including the cortex and the medulla 
(Figure 1). The early steps in T cell development are induced in the cortex, which is 
characterized by a high cell density resulting from a high degree of proliferating immature 
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thymocytes. In addition, an area of low cell density can be observed, which is known as the 
medulla. Based on phenotype and status of the TCR gene rearrangements we have gained 
significant insight in the various transitional stages of T cell development in the human 
thymus (Figure 2) (Spits et al., 1998; Spits, 2002). The ETP, lacking TCR rearrangements, are 
enclosed within a population of cells that express CD34, but lack CD1a expression. The 
downstream CD34+CD1a+ population is committed to the T cell lineage because they are 
unable to develop into non-T cells (Dalloul et al., 1999; Galy et al., 1993; Res & Spits, 1999; 
Spits et al., 1998). The cells that subsequently upregulate CD4 and downregulate CD34 are 
generally referred to as CD4 immature single-positive (CD4 ISP) (Hori et al., 1991). 
Downstream of the CD4 ISP subset are CD4+CD8+− (early double-positive) and 
CD4+CD8++ populations (Galy et al., 1993; Hori et al., 1991), which are the precursors of 
double-positive (DP) TCR+ cells. During the early stages in T cell development, the TCR 
loci undergo sequential rearrangements in the order of TCR >  > ǃ >  (Blom et al., 1999; 
Dik et al., 2005; Verschuren et al., 1998). Depending on differences in the sensitivity of the 
assay used to measure TCR rearrangements productive TCRǃ V-DJ rearrangements were 
either found in the CD34+CD1a+ cells (Dik et al., 2005) or in the CD4 ISP cells (Blom et al., 
1999). It cannot be excluded, however, that a small contamination in the sorted CD34+CD1a+ 
cells in combination with a highly sensitive PCR detection assay was responsible for the 
positive signal (Dik et al., 2005). Only productive, in-frame TCRǃ rearrangements result in 
the production of a TCRǃ protein, which together with the CD3 subunits and the invariable 
pre-TCR- (pT) chain ensures cell surface expression of a pre-TCR. At this stage a process 
referred to as ǃ-selection occurs in distinct populations of cells that differ in CD4 and CD8 
expression. Both CD4 ISP and CD4+CD8ǂ+ǃ− early double-positive subsets were found to 
contain intracytoplasmic (ic) TCRǃ− and icTCR+ cells (Blom et al., 1999; Carrasco et al., 
1999). Ten to twenty percent of the CD4 ISP are icTCRǃ+, and in contrast to the TCRǃ− CD4 
ISP, these icTCRǃ+ CD4 ISP are larger and express elevated levels of CD28 and CD71 
(Taghon et al., 2009). A larger proportion is ǃ-selected after upregulation of CD8 (Carrasco 
et al., 1999; Trigueros et al., 1998). Hence, these findings suggest that expression of a TCRǃ 
protein and the ensuing ǃ-selection occur within a certain developmental window and are 
not tightly coupled to regulation of CD4, CD8ǂ, and CD8ǃ expression. 
Activation of the pre-TCR on the cell surface induces TCR-selection, which is a collective 
process leading to survival and proliferation of the cells, allelic exclusion, and induction of 
TCRrearrangements (Spits, 2002). Subsequently, CD4+CD8+ DP T cells express a mature 
TCR complex on their cell surface, which is followed by positive and negative selection 
(Klein et al., 2009; Siggs et al., 2006). Positive selection mediated by the cortical thymic 
epithelial cells secures the survival of T cells that recognize self-major histocompatibility 
(MHC) antigens complexed with self-peptides with low/intermediate affinity. Conversely, 
high affinity self-peptide MHC complexes expressed by thymic dendritic cells (DC) in the 
medulla are pivotal for deletion of auto-reactive T cells, which is called negative selection. In 
the majority of cases when no interaction of TCR and MHC complexes can be established, 
the cells are unable to survive and die as a result of death by neglect. Positively selected 
thymocytes differentiate into T cells that express CD27 and CD45RA and high levels of 
CD3/TCR (CD3hi) similar to naive T cells present in cord blood. Finally, lineage 
determination signals enforce the differentiation into either the helper CD4+ T cell or 
cytotoxic CD8+ T cells lineages.  
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Fig. 1. Photomicrograph of the thymus. This section of human thymus (original 
magnification x10, courtesy of Dr. B. Jamieson, UCLA, Los Angeles, USA) was stained with 
hematoxylin/eosin and shows the cortex (C), which is a dense area of proliferating 
lymphocytes (thymocytes), and the medulla (M), where fewer cells localize and negative 
selection takes place. It is believed that progenitor cells enter the thymus at the cortico-
medullary junction (CMJ) before migration into the cortex and commitment into the T cell 
lineage. 
  
 
Fig. 2. Schematic model of human T cell development. Shown is the expression of cell 
surface markers on thymic progenitor cells and during the different stages of human T cell 
development in the thymus (black indicates expression, white indicates no expression). In 
addition, the status of T cell receptor (TCR)  and gene rearrangements is shown. 
Hematopoietic stem cell (HSC), common lymphoid progenitor (CLP), early thymic 
progenitor (ETP), immature single positive (ISP), early double positive (EDP), single 
positive (SP), germline (GL), Diversity-Joining TCR(D-J), Variable-DJ TCR(VDJ), 
Variable-Joining TCR (VJ). 
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4. Role of cytokines in T cell development 
A role for interleukin (IL)-7 in the development of T cells in the thymus has been 
highlighted by many groups. The IL-7 receptor consists of two chains, IL-7R and gamma 
common (c), which is also part of the receptors for IL-2, IL-4, IL-9, IL-15, and IL-21. Genetic 
defects in the genes encoding for c (Noguchi et al., 1993; Russell et al., 1993), IL-7R (Giliani 
et al., 2005; Puel et al., 1998), or the Janus kinase Jak3, a component of the IL-7-induced 
signal transduction pathway (Macchi et al., 1995; Russell et al., 1995), account for the 
majority of severe combined immune deficiencies (SCID). This disease is characterized by 
strongly reduced numbers of T cells. The most frequent form of SCID is caused by 
mutations in the c-encoding gene (reviewed in (Fischer et al., 2005)). In these patients, T 
and NK cells are absent, but in contrast to what is observed in c-deficient mice, B cell 
development is normal (Noguchi et al., 1993; Russell et al., 1993). While IL-7R-deficient 
patients also display a profound T cell deficiency, they have near normal NK and B cell 
numbers (Giliani et al., 2005; Puel et al., 1998). This indicates that human T cell 
development, but not survival and proliferation of lymphoid precursors, specifically and 
critically depends on IL-7. The precise function of IL-7, which is produced by thymic 
epithelial cells, in human T cell development remains incompletely understood. Expansion 
and differentiation of developing T cells in a FTOC is inhibited by blocking the IL-7R 
signaling pathway using anti-IL-7 and anti-IL-7R antibodies (Pallard et al., 1999; Plum et al., 
1996). This indicates that IL-7 has a crucial role in mediating survival and proliferation of 
human T cell precursors. It has been reported that this is likely mediated by IL-7-induced 
Phosphoinositide Kinase-3 (PI3K) activation through one tyrosine residue at position 449 in 
the cytoplasmic tail of the IL-7R chain (Pallard et al., 1999). Based on the notion that the 
distribution of subsets in the thymuses of IL-7R-deficient mice was near normal, it was 
argued that IL-7 does not appear to be critical for differentiation of mouse TCR T cells in 
the thymus (Peschon et al., 1994). In humans, however, there is evidence that IL-7 is 
important for differentiation of human T cells. First, differentiation of CD34+ precursors in a 
FTOC in the presence of anti-IL-7R antibody is almost completely blocked at the transition 
of CD34+CD1a+ cells into CD4 ISP (Plum et al., 1996). Second, according to one report, 
thymocytes from c-deficient infants possess TCRǃ D-J but lack V-DJǃ rearrangements 
(Sleasman et al., 1994). Although a function of IL-7 in TCRǃ rearrangements in human pre-T 
cells has yet to be confirmed, it may reflect the complete lack of T cells in many c- and IL-
7R-deficient patients (Giliani et al., 2005; Pesu et al., 2005). Conversely, IL-7 is required for 
peripheral T cell homeostasis in humans (Napolitano et al., 2001), which raises the 
alternative possibility that the combined defects in early T cell development and in T cell 
homeostasis are causal to the absolute T cell deficiency in c-deficient patients. Collectively, 
these results indicate that IL-7 is indispensable for human T cell development, and 
moreover suggests that IL-7 is more critical for human than for mouse T cell development. 
5. HIV tropism vs. thymic architecture 
HIV can enter the cell through two major co-receptors, CXCR4 and CCR5, which are 
chemokine G-protein coupled receptors. Under physiological conditions CXCR4 ligates the 
chemokine CXCL12/SDF-1, while CCR5 can be engaged by several chemokines, including 
RANTES (CCL5) or the macrophage inflammatory proteins MIP-1ǂ (CCL3) and MIP-1ǃ 
(CCL4) (Rossi & Zlotnik, 2000). Based on the expression pattern of these chemokine 
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receptors on leukocytes a clear distinction can be made between CXCR4 (X4)-tropic and 
CCR5 (R5)-tropic viruses (Deng et al., 1996; Dragic et al., 1996; Feng et al., 1996). In bone 
marrow, on average 40% of the CD34+ progenitor cells express the chemokine receptor 
CXCR4 (Ishii et al., 1999). This subset was shown to have restricted lymphoid precursor 
activities, and resemble the CD34+CXCR4+ cells in neonatal UCB, which are likely the 
precursors of human CLPs (Haddad et al., 2004; Hao et al., 2001). CCR5 is expressed on the 
cell surface of only a minority of freshly isolated CD34+ CB cells (1–21%), although at the 
intracellular level more than 80% of the CD34+CB cells expressed abundant CCR5 receptors 
(Basu & Broxmeyer, 2009). While chemotaxis of CD34+CB cells was not induced by the 
CCR5 ligands CCL3, CCL4 and CCL5, they transiently enhanced chemotaxis mediated by 
CXCL12, the ligand for CXCR4 (Basu & Broxmeyer, 2009). Whether CD34+ cells can be 
infected by HIV has been the subject of great discussion through the years. Recently, Carter 
et al. (Carter et al., 2010) demonstrated that CD34+ cells can be infected by both X4 and R5-
tropic viruses in vitro as well as in vivo, thus potentially becoming a significant reservoir of 
HIV. In the thymus, both CXCR4 and CCR5 are expressed as well (Figure 3) (Berkowitz et 
al., 1998b; Gurney & Uittenbogaart, 2006; Kitchen & Zack, 1997; Kitchen & Zack, 1999; 
Pedroza-Martins et al., 1998; Zaitseva et al., 1998; Zamarchi et al., 2002; Zhang et al., 1998). 
Several studies have shown that expression of CXCR4 and CCR5 are modulated during 
thymocyte development (Berkowitz et al., 1998b; Gurney & Uittenbogaart, 2006; Zaitseva et 
al., 1998). CXCR4 is expressed on the majority of thymocytes at all stages of differentiation 
with the highest level of CXCR4 expression on the CD34+ and CD4 ISP subsets (Berkowitz et 
al., 1998b; Hernandez-Lopez et al., 2002; Zaitseva et al., 1998). It was observed that CXCL12, 
in synergy with IL-7, mediates survival of these thymic progenitor subsets (Hernandez-
Lopez et al., 2002). In accord with its co-receptor profile, CD4 ISP cells are infected with X4-
tropic HIV-1, which has a cytopathic effect in the thymus resulting in a major depletion of 
cells (Gurney & Uittenbogaart, 2006; Kitchen & Zack, 1997). On more mature stages of T cell 
development CXCR4 is downregulated (Berkowitz et al., 1998b; Gurney & Uittenbogaart, 
2006; Zaitseva et al., 1998). Notably, however, infected CD8+ T cells are detected in the HIV-
1 infected thymus, which can be explained by the observation that immature thymocytes, 
before they have differentiated into single positive thymocytes, can be infected by X4-tropic 
HIV-1 (Gurney & Uittenbogaart, 2006; Kitchen & Zack, 1997; Lee et al., 1997). Just prior to 
emigration from the thymus CXCR4 is again upregulated (Gurney & Uittenbogaart, 2006). 
Taken together, X4-tropic viruses can infect cells that are present in both the cortex and the 
medulla (Jamieson et al., 1995; Uittenbogaart et al., 1996). It is important to keep in mind 
that most of this work has been done with HIV laboratory strains that are highly cytopathic 
and may not be representative of what is happening in vivo in humans. This is enforced by 
the finding that HIV pediatric isolates from newborn children are not as cytopathic as the 
laboratory strains in infecting thymocytes at least in vitro (Pedroza-Martins et al., 1998).  
Unlike CXCR4, the expression of CCR5 is much less widespread (Berkowitz et al., 1998a). 
CCR5 is detected on a relatively small proportion of thymocytes, including mature CD4 and 
CD8 single positive T cells which express CD27 but lack CD45RA (Berkowitz et al., 1998b; 
Gurney & Uittenbogaart, 2006), and is downregulated just prior to exiting the thymus 
(Berkowitz et al., 1998a; Gurney & Uittenbogaart, 2006). R5-tropic viruses are less 
cytopathic, which may at least in part be explained by the restricted co-receptor expression 
on a small subset, resulting in a much slower depletion of thymocytes (Jamieson et al., 1995). 
Moreover, the CCR5 expressing thymocytes are confined in the medullary area, which 
constrains prevalent replication of R5 viruses throughout the thymus (Berkowitz et al., 
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1998a). Notably, like X4-tropic viruses, R5 strains are capable of depleting thymocytes 
leading to reduced cellularity in the thymus. One explanation can be that in addition to 
TCR+ T cells, other CCR5+ cells are found in the thymus, including conventional DC 
(cDC), plasmacytoid DC (pDC), macrophages, CD161+ T cells and Ǆǅ T cells (Gurney et al., 
2002; Gurney et al., 2004; Keir et al., 2002; Rozmyslowicz et al., 2010; Schmitt et al., 2006). 
Another explanation can be that pDC (see paragraph below) in response to the virus 
produce large amounts of type I IFNs (Gurney et al., 2004), which contributes to immune 
activation followed by cell death and T cell depletion. The pDC are likely more susceptible 
to R5-tropic HIV infection as they express CCR5 at higher levels compared to single positive 
thymocytes (Gurney et al., 2004). It was recently reported that IFN- induced expression of 
CCR5 on CD4 ISP thymocytes, which consequently expands the tropism for R5-tropic 
viruses (Stoddart et al., 2010). This, together with the observation that thymi from HIV-
infected individuals present with higher CCR5 expression on mature thymocytes as 
compared with thymocytes from uninfected individuals (Bandera et al., 2010), enforces the 
notion that immune activation has a detrimental role in thymic depletion. 
 
 
Fig. 3. Expression of chemokine receptors CXCR4 and CCR5 on cells at different stages 
during T cell development in the human thymus. The solid line arrows indicate high 
expression of the different cell surface markers, while the dotted line arrow indicates low 
expression. T cell receptor (TCR), single positive (SP). 
6. Role of pDC in HIV pathogenesis in the thymus 
Rare immune subsets like DC, play significant roles in the regulation of the immune system 
(Banchereau et al., 2000a; Banchereau et al., 2000b; Cella et al., 1999; Cella et al., 2000; 
Grouard et al., 1997; Kadowaki et al., 2000). Among the different types of DC subsets are 
pDC, which are present in cord and peripheral blood, T cell areas of the lymph nodes and in 
the medullary area of the thymus, and have the capacity to produce high levels of type I 
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IFN, i.e. IFN and IFN in response to viruses and other stimuli (Bendriss-Vermare et al., 
2001; Cella et al., 1999; Foster et al., 2000; Kadowaki et al., 2000; Olweus et al., 1997; Res et 
al., 1999; Siegal et al., 1999; Vandenabeele et al., 2001). Type I IFNs are survival factors for 
pDC, while maturation of pDC depends on IL-3 (Grouard et al., 1997). Exposure of 
peripheral blood pDC to virus, or alternatively IFN- or IL-3 either in combination with 
CD40L or TNF-ǂ, leads to the appearance of pDC with a mature phenotype illustrated by 
the finding that they express increased levels of HLA Class II and costimulatory molecules 
(Kadowaki et al., 2000; Kohrgruber et al., 1999). PDC can differentiate in vitro into mature 
DC capable of stimulating CD4+ naïve T cells to proliferate and differentiate, and depending 
on the environmental signals polarize T cells into T helper 2 (Th2) (Rissoan et al., 1999) or 
Th1 cells (Cella et al., 2000). Also, pDC have the ability to shape CD8+ T cell responses either 
directly (Gilliet & Liu, 2002) or via crosspressentation (Hoeffel et al., 2007), and NKT cell 
responses (Kadowaki et al., 2001a). However, the central role of pDC in vivo is likely that of 
an IFN-ǂ/ producing cell, and not an antigen presenting cell (Haeryfar, 2005).  
In response to enveloped RNA and DNA viruses (Milone & Fitzgerald-Bocarsly, 1998), 
including live and inactivated HIV-1 (Beignon et al., 2005; Ferbas et al., 1994; Fong et al., 
2002; Hardy et al., 2007; Yonezawa et al., 2003), human pDC are the main producers of 
IFN-ǂ (Ferbas et al., 1994; Ishikawa et al., 2005; Milone & Fitzgerald-Bocarsly, 1998; Siegal et 
al., 1999). In contrast to conventional cDC, pDC do not produce interleukin-12 (IL-12) (Ito et 
al., 2006). The capacity of IFN-ǂ production in response to virus is already present at the 
pro-pDC stage (Blom et al., 2000) and can be sustained during activation and maturation 
(Cella et al., 1999). IFN-ǂ produced by pDC induces maturation of conventional cDC and 
thereby provides a link between innate and adaptive immunity (Ito et al., 2001). Several 
viral infections induce IFN-ǂ, but the pathways that lead to IFN-ǂ production are likely 
different. Recent reports suggest that in HIV-1 infection IFN-ǂ production by pDC is 
stimulated through interaction of HIV-1 RNA with Toll like receptor (TLR)7 (Beignon et al., 
2005; Hardy et al., 2007; O'Brien et al., 2011). Although it has been shown that pDC can be 
productively infected by R5-tropic and X4-tropic HIV-1 (Gurney et al., 2004; Keir et al., 
2002), IFN-ǂ production by pDC does not depend on productive HIV-1 infection (Beignon et 
al., 2005; Hardy et al., 2007). Furthermore, pDC express TLR9, which after engagement by 
oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs mimicking bacterial 
DNA, activate the cells to secrete high levels of type I IFNs (Kadowaki et al., 2001b).  
Development of pDC both in human and mouse depends on FLT3L (Blom et al., 2000; Gilliet 
et al., 2002). Furthermore, the Ets transcription factor Spi-B and the basic helix-loop-helix 
factor E2-2 are essential for the development of human pDC in vitro as well as in vivo (Cisse 
et al., 2008; Nagasawa et al., 2008; Schotte et al., 2003; Schotte et al., 2004). In the human 
thymus a cell type very similar to peripheral pDC was identified. These CD3- cells express 
CD4, CD45RA and high levels of CD123 and are localized at the cortico-medullary junction 
and in the medulla (Bendriss-Vermare et al., 2001; Olweus et al., 1997; Res et al., 1999; 
Schmitt et al., 2000; Vandenabeele et al., 2001). There are similarities but also differences 
between thymic and peripheral pDC. Both thymic and peripheral pDC respond, in addition 
to IL-3, also to GM-CSF (Ghirelli et al., 2010; Vandenabeele et al., 2001). Like the peripheral 
pDC, the thymic pDC have the capacity to develop into mature DC, but some differences 
were observed in the expression of certain cell surface antigens (Res et al., 1999). Thymic 
pDC consistently express CD2, CD5 and CD7, while peripheral pDC do not express CD7 
and are heterogeneous with respect to the expression of CD2 and CD5 (Bendriss-Vermare et 
al., 2001; Res et al., 1999; Schmitt et al., 2006). Interestingly, thymic pDC constitutively 
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express low levels of IFN-ǂ, which is upregulated by HIV-1 infection in vivo (Gurney et al., 
2004). Moreover, thymic pDC produce less IFN-ǂ upon infection with virus (Schmitt et al., 
2006). These differences may imply either that thymic and peripheral pDC are different 
subsets, or that these alterations are enforced by the thymic microenvironment.  
The role of pDC in controlling HIV-1 replication is still incompletely resolved. Several 
reports describe a decrease in frequency and function of peripheral blood pDC in HIV-1-
infected patients (Chehimi et al., 2002; Donaghy et al., 2001; Feldman et al., 2001; 
Pacanowski et al., 2001; Soumelis et al., 2001). A decrease in pDC has been correlated with 
an increase in HIV-1 RNA virus load and opportunistic infections, suggesting that a loss of 
these cells may contribute to disease progression in HIV-1-infected patients (Donaghy et al., 
2001; Siegal et al., 2001). This decrease in peripheral blood pDC may be due to HIV-1 
induced cell death or migration of pDC from the peripheral blood to lymphoid tissues. In 
accord with the latter option, it was reported that HIV-1 infection induces pDC maturation 
resulting in expression of CCR7 and migration to lymph nodes (Schmidt et al., 2005), which 
is a major site of HIV-1 pathogenesis (Herbeuval et al., 2006). While pDC can suppress HIV-
1 replication in vitro (Gurney et al., 2004; Yonezawa et al., 2003) and ex vivo (Meyers et al., 
2007), pDC through their production of IFN-ǂ have also been found to contribute to HIV 
pathogenesis by TRAIL-mediated apoptosis of uninfected CD4+ T cells (Herbeuval et al., 
2006). Recent data suggest that despite a decrease in pDC numbers in peripheral blood of 
HIV infected individuals, their production of TLR7/8 agonist induced cytokine/chemokine 
is even higher than that of pDC of non-infected individuals thereby contributing to chronic 
immune activation (Sabado et al., 2010). With respect to thymic pDC, these are also targets 
for CXCR4- and CCR5-tropic HIV as they express CD4 in addition to both CXCR4 and 
CCR5. Notably, the expression level of CCR5 on pDC is higher than on thymocytes, 
suggesting that pDC are more susceptible to CCR5-tropic HIV infection than thymocytes 
(Gurney et al., 2004; Ho Tsong Fang et al., 2008; Schmitt et al., 2000). Studies in the SCID-hu 
Thy/Liv mouse model (see paragraph on “Humanized mouse models to study HIV-1 
immuno-pathogenesis”) show that pDC are productively infected by HIV and that HIV 
infection induces IFN- production resulting in upregulation of MHC-I and the interferon 
stimulated gene (ISG), MxA (Gurney et al., 2004; Keir et al., 2002; Schmitt et al., 2006). 
Recently, the suggestion was raised that as a consequence of upregulated MHC-I expression 
levels in the thymus, the generation of dysfunctional CD8+ T cells with low expression of 
CD8 was induced resulting from altered negative selection (Favre et al., 2011). While no 
conclusive evidence was presented, when true this may have detrimental effects on 
thymopoiesis in the HIV-1-infected thymus, and contribute to the immunodeficiency of HIV 
disease. 
7. Impact of IFN-alpha on T cell regeneration 
Type I IFNs, including IFN- and –, are important cytokines that have been classically 
described to have an immunoregulatory function with central roles as antiviral mediators 
(Brassard et al., 2002; Grandvaux et al., 2002). However, type I IFNs have additional effects 
besides their well-known antiviral function. It has been shown that high concentrations of 
IFN- interfered with T and B cell development in mice (Lin et al., 1998). In the thymus, an 
80% decrease in the overall cellularity and a 50% reduction of the CD4+CD8+ DP population 
was observed (Lin et al., 1998). Considering the key role of IL-7 during T cell development 
(see paragraph above “Role of cytokines in T cell development”) it was speculated that type 
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I IFNs might interfere with IL-7 signaling. Consistent with this it was shown that type I IFNs 
inhibited IL-7-driven expansion of CD4-CD8-CD44+CD25+ (also known as double negative 
(DN)2) cells in murine fetal thymus organ cultures (Su et al., 1997).  
The main producers of type I IFNs are pDC, which express TLR7 and TLR9 enabling them 
to sense nucleic acids derived from viruses or bacteria (Kadowaki et al., 2001b; Cella et al., 
1999; Kadowaki et al., 2000). In addition to secondary lymphoid organs and peripheral 
blood, pDC are present in the thymus, where they locate in the medulla and at the cortico-
medullary junction (Bendriss-Vermare et al., 2001; Res et al., 1999; Vandenabeele et al., 
2001). As this latter location is where TSP cells enter the thymus, it is conceivable that 
thymic pDC affect T cell development. In line with this it was demonstrated that IFN- 
when exogenously added as recombinant protein, impaired early human T cell 
development by interfering with the IL-7 signaling pathway (Schmidlin et al., 2006). 
Moreover, similar findings were observed when pDC were activated either by HIV-1 or the 
TLR9 agonist CpG-ODN in a co-culture setup in which thymic progenitor cells were 
induced to differentiate into both T cells and pDC (Schmidlin et al., 2006). Addition of 
neutralizing antibodies against type I IFNs in this system relieved the block in T cell 
development illustrating that type I IFNs produced by activated pDC have a detrimental 
effect on early T cell progenitor cells (Schmidlin et al., 2006). It remains largely elusive 
whether type I IFNs affect later stages of T cell development. This is not unlikely, however, 
given the architectural localization of pDC in the medulla, and the finding that the majority 
of thymocytes express the type I IFN receptor (CD118) on their surface (Keir et al., 2002). In 
fact, IFN-ǂ was reported to interfere with IL-7–induced maturation at the transition of 
human CD3+CD1a+ to CD3+/hiCD1a– thymocytes (Schmidlin et al., 2006). In addition, IFN- 
induced the up-regulation of MHC class I expression in the thymus (Keir et al., 2002). This 
may cause adverse T cell selection in the thymus by changing the avidity of the TCR for 
MHC potentially depleting part of the mature CD8+ T cell repertoire. 
8. Role of regulatory T cells in HIV pathogenesis in the thymus 
CD4+CD25+ regulatory T (Treg) cells are a distinct subset of CD4+ T cells, which play a 
significant role in the generation and maintenance of peripheral tolerance (Maloy & Powrie, 
2001; Sakaguchi, 2000; Sakaguchi, 2005). Although in humans Treg cells in the periphery 
constitute a small subset of the total T-cells (1%-2%) (Baecher-Allan et al., 2001), there is 
accumulating evidence that they play a significant role in the negative control of a broad 
spectrum of immune responses to antigens, such as in tumor immunity, organ 
transplantation, allergy, and microbial immunity (reviewed in (Sakaguchi, 2005)). Treg cells 
are identified by their constitutive expression of the alpha chain of the interleukin 2 (IL-2) 
receptor (CD25) and the presence of the forkhead/winged-helix transcription repressor 
FoxP3 (scurfin) (Baecher-Allan et al., 2001; Fontenot et al., 2003; Hori et al., 2003; Khattri et 
al., 2003; Yagi et al., 2004). There is mounting evidence that FoxP3 plays a crucial role in the 
development and function of human (Walker et al., 2003; Yagi et al., 2004) and murine 
(Fontenot et al., 2005) CD4+CD25+ Treg cells (reviewed in (Fontenot & Rudensky, 2005)). In 
addition to FoxP3, the cytokine IL-2 is essential for the development of Treg cells in the 
thymus and their maintenance in the periphery (reviewed in (Sakaguchi, 2005)). Although 
Treg cells show low levels of proliferation in vitro (Baecher-Allan et al., 2001), peripheral 
expansion of thymus-derived natural Treg (nTreg) cells ensures maintenance of the 
peripheral Treg pool in the adult mouse (Hori et al., 2002). In addition, antigen-dependent 
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proliferation of Treg cells has been shown in vivo (Klein et al., 2003b; von Boehmer, 2005). 
The mechanism of T cell suppression by Treg cells is dependent on direct cell-cell contact 
(reviewed in (von Boehmer, 2005)). However, in addition to the direct effects of Treg cells, 
bystander effects include the production of cytokines (IL-10 and TGF-) that have 
suppressive effects on immune responses (reviewed in (von Boehmer, 2005)). 
In mice and rats as well as humans, nTreg cells develop intrathymically (Jordan et al., 2001; 
Kasow et al., 2004) and acquire their regulatory function while still in the thymus (Itoh et al., 
1999; Saoudi et al., 1996; Stephens et al., 2001). Treg cells are continuously produced in the 
thymus as a distinct lineage contiguous with peripheral blood Treg cells (reviewed in 
(Fontenot et al., 2005; Sakaguchi, 2005)). There is recent evidence that thymic pDC play a 
role in the development of nTreg (Hanabuchi et al., 2010; Martin-Gayo et al., 2010). Both 
pDC and Treg cells are located closely together in the thymic medulla, which may suggest 
interactions between them (Martin-Gayo et al., 2010; Res et al., 1999; Watanabe et al., 2005). 
In addition to the induction of Treg cells by cDC activated with the IL-7 like cytokine thymic 
stromal lymphopoietin (TSLP) (Watanabe et al., 2005), FoxP3+ Treg cells can also be induced 
in the thymus by pDC after these have been stimulated with TSLP (Hanabuchi et al., 2010). 
The role of TSLP activation of pDC in the development of thymic Treg is however still 
unclear as Martin-Gayo et al. found that thymic pDC were unresponsive to TSLP, but 
responsive to CD40L and IL-3 (Martin-Gayo et al., 2010). It is interesting to note that nTreg 
cells generated in the presence of cDC have opposite IL-10/TGF- cytokine profiles from 
those generated wih pDC (Martin-Gayo et al., 2010). Thus, the interaction of pDC and cDC 
with Treg cells may play an important role in the development of tolerance in the thymus.  
In contrast to adult peripheral blood, Treg cells in the human fetal and postnatal thymus 
(Annunziato et al., 2002; Cupedo et al., 2005; Kasow et al., 2004) and in cord blood (Takahata 
et al., 2004; Thornton et al., 2004) have a naïve phenotype, although they suppress the 
proliferation of CD25-negative T cells, similar to Treg cells in the periphery. Treg cells 
identified by high expression of CD25 and FoxP3 are already present in the human fetal 
thymus and secondary lymphoid organs (Cupedo et al., 2005; Darrasse-Jeze et al., 2005). T 
cells expressing GITR, CTLA-4 and CD122 and high levels of CD25, corresponding to the 
phenotype of Treg cells, develop in the human thymus at the CD4+CD8+ stage during 
transition of CD27- to CD27+ stage (Cupedo et al., 2005). When Treg cells leave the thymus 
and enter fetal secondary lymphoid tissues, lymph nodes and spleen, they acquire a 
memory/activated phenotype (Cupedo et al., 2005). In the normal functioning immune 
system there is a balance between the interactions of Treg cells and effector T cells, whereas 
deficiency of functional Treg cells leads to inappropriate immune responses to microbial 
infections and autoimmunity as exemplified in humans who suffer from the X-linked 
immunodeficiency syndrome (IPEX) with a mutation in FoxP3 (reviewed in (Fontenot et al., 
2005; Sakaguchi, 2005)). In addition to CD4+ Treg cells, CD8+CD25+ Treg cells have been 
identified in the thymus (Cosmi et al., 2003). The CD8+CD25+ Treg cells express FoxP3 
mRNA, but lower levels of CD25 than the CD4+ Treg cells (Cosmi et al., 2003). 
There is ample evidence that Treg cells play a significant role in infectious diseases 
including viral infections (reviewed in (Belkaid & Rouse, 2005; Mills & McGuirk, 2004)). In 
humans, circulating peripheral Treg cells suppress CD4+ and CD8+ antiviral immune 
responses in chronic viral infections, such as HCV (Cabrera et al., 2004), CMV and HIV 
(Aandahl et al., 2004; Andersson et al., 2005; Eggena et al., 2005; Kinter et al., 2004; Oswald-
Richter et al., 2004; Weiss et al., 2004). There is a clear measurable restoration of antiviral 
immune responses to CMV and HIV in vitro when CD4+CD25+ T cells are completely 
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removed (Aandahl et al., 2004; Weiss et al., 2004). Although Treg cells produce 
immunosuppressive cytokines, IL-10 and TGF-1 in response to p24 antigen stimulation, the 
down modulation seen by CD4+CD25+ T cells is cell-cell contact dependent and independent 
of IL-10 and TGF- (Kinter et al., 2004; Weiss et al., 2004). The impact of Treg cells on HIV-1 
infection is still unclear and may depend on the stage of infection. Early in viral infection, 
the proportion of Treg cells is unaltered as compared to normal controls (Aandahl et al., 
2004). Elevated levels of circulating HIV specific CD25hiCD4+ T cells were observed in a 
majority of healthy, yet chronically, HIV infected individuals (Kinter et al., 2004). However, 
Treg cell numbers declined proportionately with the loss of CD4+ T cells and disease 
progression (Kinter et al., 2004; Oswald-Richter et al., 2004). Treg cells were increased in 
tonsils, but decreased in the peripheral blood of untreated chronically HIV infected 
individuals, indicating that viral antigenic stimulation may have increased Treg cells in the 
lymphoid tissue and may have a detrimental effect on local immune responses (Andersson 
et al., 2005). A recent study in HIV infected individuals undergoing cardiac surgery showed 
that Treg cells were increased in the thymus of HIV-infected individuals as compared to 
uninfected individuals (Bandera et al., 2010). In a study of treatment naïve, chronically HIV 
infected individuals in Uganda, depletion of Treg cells was associated with immune 
activation (Eggena et al., 2005). The underlying mechanism suggests a complex balance 
between Treg cells and effector T cells. In summary, it will be of significant clinical value to 
determine at which stages of disease and in which tissues Treg cells have detrimental or 
protective effects on the immunopathology observed in HIV infection.  
9. SIV pathogenic and non-pathogenic models 
The use of animal models has been of great importance to study the thymus in HIV 
infection. In this regard the non-human primate models, and the SCID-hu and humanized 
mouse models, as discussed in the next section, are providing a great deal of knowledge on 
the role of the thymus in HIV infection. Studies in pathogenic and non-pathogenic models of 
simian immunodeficiency virus (SIV) infected non-human primates have further increased 
our understanding on the role of the thymus in HIV infection. In the non-pathogenic model 
SIV infection of its natural hosts (chimpanzees, sooty mangabeys, African green monkeys, 
and others) does not lead to depletion of CD4+ T lymphocytes and AIDS, in contrast to the 
pathogenic model in which SIV infects its non-natural host (rhesus macaques) (reviewed in 
(Silvestri, 2008)). Effective innate immune responses including IFN- and ISG are induced, 
but rapidly controlled in acute SIV infection of sooty mangabeys (SM) (Bosinger et al., 2009) 
and African Green monkeys (Diop et al., 2008; Jacquelin et al., 2009). However, acute SIV 
infection of rhesus macaques (RM) induces chronic immune activation and continuous 
expression of ISG (Bosinger et al., 2009). An increase in the ISG, MxA mRNA was found in 
lymphoid tissues, including the thymus, in SIV infected rhesus macaques. However, the 
elevated MxA levels did not correlate with control of viral infection in the animals (Abel et 
al., 2002) and are likely a sign of immune activation. Non-responsiveness to TGF-1 was 
found to play a role in the lack of resolution of immune activation in rhesus macaques 
(Ploquin et al., 2006). Chronic immune activation was recognized many years ago as a major 
player in poor prognosis HIV infected individuals (Giorgi et al., 1999). Thus interference 
with immune activation was explored by administration of an antibody to the IFN- 
receptor in SIV infected macaques, which reduced the loss of CD4+ T cells in these animals 
(Tovey et al., 1994). 
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Studies of lymphoid tissues in SIV infected macaques have shed light on the differences 
between changes in T lymphocytes in peripheral blood and primary (thymus) and 
secondary lymphoid organs. In the thymus and secondary lymphoid organs proliferation of 
T lymphocytes and absolute CD4+ T lymphocytes were increased in acute SIV infection, but 
decreased in peripheral blood (Sopper et al., 2003). However in animals with first indication 
of AIDS, thymocytes were severely decreased (Sopper et al., 2003). Increased levels of 
thymocyte proliferation were also observed by Wykrzykowska et al. (Wykrzykowska et al., 
1998) after an initial increase in apoptosis and depletion of thymic progenitors. Apoptosis in 
SIV infected macaques correlated with peak viremia and disruption of the apoptotic 
pathway (Rosenzweig et al., 2000). Pathogenicity of the virus on the level of apoptosis in the 
thymus was observed in macaques infected with a pathogenic and non-pathogenic HIV/SIV 
hybrid virus (SHIV) (Iida et al., 2000). Recent thymic emigrants can be determined by 
measuring T cell receptor excision circles (TRECs) in peripheral blood and provide a mirror 
of thymic function. Increased or stable levels of TRECs were found early after infection, but 
TREC levels decreased later when depletion of CD4+ thymocytes and apoptosis were 
observed in one of the animals (Sodora et al., 2002). Elevated TREC levels as compared to 
non-infected controls were observed in macaques infected with a less pathogenic SIVnef 
virus indicating that the thymus can maintain its function in the presence of low viral loads 
(Ho Tsong Fang et al., 2005). However the thymus as the major player in maintaining naïve 
peripheral CD4+ T cells has been disputed. Proliferation of peripheral T lymphocytes does 
also play a role in maintaining peripheral T cell homeostasis. Thymectomies of juvenile SIV 
infected macaques showed that TRECs in peripheral blood decreased after thymectomies. 
However, thymectomy in the SIV infected animals did not impact their clinical course or the 
ratio of CD45RA+ to CD45RA-CD4+ T cells (Arron et al., 2005). 
10. Humanized mouse models to study HIV-1 immuno-pathogenesis 
A small, easy-to-handle animal model that would facilitate the study of the pathophysiology 
of acute HIV-1 infection has been warranted after we were confronted with the HIV 
pandemic in the 1980s. Normal mice cannot be studied due to the limited species tropism of 
HIV, and therefore humanized mouse models have been instrumental to study HIV 
infections. Over the last decades significant progress has been made in the generation of 
humanized mouse models (Figure 4) with a functional human immune system, which has 
not only added to our insight into the development of human stem cells and the 
reconstitution of a human immune system in an in vivo setting, but also initiated studies on 
the preclinical testing of novel antiviral compounds, and the evaluation of vaccines.  
Initially, humanized mice were generated using mice with the scid mutation in the C.B-17 
mouse strain (Bosma et al., 1983). Such mice lack mature T and B cells due to a mutation in 
the prkdc gene, which is involved in rearrangement of TCR and Ig genes (Kirchgessner et al., 
1995). Adoptive transfer of human peripheral blood lymphocytes (PBL) in C.B-17 SCID 
mice, which is commonly referred to as the human (hu) PBL-SCID model, resulted in the 
reconstitution of mature human T and B cells (Mosier et al., 1988). Although these 
transferred human lymphocytes only survived for a short period of time limiting long-term 
studies, hu-PBL-SCID mice have been used to study certain aspects of HIV-1 infection, 
including the importance of the state of activation of human CD4+ T cells at the time of 
primary infection in determining HIV-1 pathogenicity (Fais et al., 1999; Rizza et al., 1996). 
Resolutions to bypass the limited survival time of human lymphocytes were obtained by the 
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transfer of human pluripotent progenitor cells ensuring development of multiple 
hematopoietic lineages. In such an optimized setting, human fetal thymic (FT) lobes and 
pieces of fetal liver (FL) were transplanted under the kidney capsule in C.B-17 SCID mice 
(McCune et al., 1988). In this hu-thymus (Thy)/liver (Liv) SCID mouse model almost 
exclusively T cells developed, which transiently migrated from the human thymus graft to 
the periphery. When compared to the first model, also this latter model suffers from the 
disadvantage that human T cell survival is reduced, although this is more apparent later 
after transplantation. This hu-Thy/Liv-SCID model has been extensively used for the 
analysis of human hematopoiesis, especially T cells, and as an animal model of HIV 
infection (McCune, 1997). HIV-1 injection in the thymic implant of hu-Thy/Liv-SCID mice 
resulted in significant HIV-1 infection not only in the Thy/Liv implant, but also in the 
spleen and peripheral blood, which indicated that HIV-1 infection could spread from the 
thymus to the peripheral lymphoid compartment (Kollmann et al., 1994). The effect of HIV-1 
infection on thymocyte maturation and depletion depended upon the strain of HIV-1 
infecting the thymus (Kollmann et al., 1995).  
  
 
Fig. 4. Humanized mouse models to study HIV-1 infection in vivo. Several ways to generate 
humanized mouse models have been established (see text for further details). Human 
peripheral blood lymphocytes (hu-PBL) are injected in severe combined immunodeficient 
(SCID) mice to generate hu-PBL-SCID mice. Pieces of fetal liver (Liv) and thymus (Thy) can 
be grafted in SCID mice to generate the hu-Thy/Liv-SCID mouse. To create a human 
immune system (HIS) mouse, newborn immunodeficient mice are injected intrahepatically 
with CD34+CD38- human stem cells (HSC) after cell sorting from the fetal liver (or 
alternatively cord blood, bone marrow, mobilized peripheral blood, not shown). 
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To further optimize the humanized mouse model approaches were established to 
repopulate sublethally irradiated C.B-17 SCID mice with progenitor cells from human bone 
marrow or umbilical cord blood (Lapidot et al., 1992; Vormoor et al., 1994). In addition to 
development of T cells these mice also developed B cells and myeloid cells, which presented 
the potential to establish a humanized mouse model with a functional human immune 
system. Ablation of mouse NK cells further increased the frequency of thymopoiesis in 
animals reconstituted with human umbilical cord blood cells. This was not only 
demonstrated when using antibodies to deplete mouse NK cells (Kerre et al., 2002), but also 
when using recipient mice with a NK cell deficient genetic background (Greiner et al., 1998). 
Reconstitution of mice that are either defective in NK cell activity (non-obese diabetic 
(NOD)/SCID mice (Ogasawara et al., 2003) or NOD/SCID/ǃ2m–/– mice (Kollet et al., 2000) 
or have impaired NK cell development (NOD/SCID/Ǆc–/– mice (Hiramatsu et al., 2003) 
were shown to have improved human T cell development. Despite their promise, however, 
repopulation of human T cells in the periphery of these mice are suboptimal (Hiramatsu et 
al., 2003; Kerre et al., 2002; Kollet et al., 2000). In addition to the genetic background, also the 
age of the mice upon reconstitution of HSC appears crucially important. Several groups 
observed that injection of human HSC to sublethally irradiated newborn BALB/c Rag2–/–c–
/– (BALB-Rag/) mice improved the reconstitution success rate (Gimeno et al., 2004; 
Traggiai et al., 2004). More than 80% of these humanized mice, either referred to as "human 
adaptive immune system Rag2–/–c–/– mice" (huAIS-RG) (Traggiai et al., 2004) or “human 
immune system BALB-Rag2–/–c–/–” (HIS BALB-Rag/) (Gimeno et al., 2004), exhibited at 
least 10% or more human CD45+ cells in peripheral blood and other lymphoid organs. 
Similar improvements were observed in newborn NOD/SCID/Ǆc–/– (NOG) mice (Ishikawa 
et al., 2003; Ishikawa et al., 2005; Ito et al., 2002; Shultz et al., 2005) and to a lesser extent in 
newborn NOD/SCID/2m–/– mice when used as recipient of HSC (Kollet et al., 2000). 
Part of the human CD4+T cells in the spleen and peripheral blood of NOG mice express the 
co-receptors CXCR4 and CCR5 (Watanabe et al., 2007). In the thymus, CXCR4 is expressed 
on the majority of CD4+CD8+ thymocytes as well as on small numbers of CD4+CD8– cells 
and CD4–CD8+ cells, while CCR5 was only expressed on a minor proportion of the 
thymocytes (Watanabe et al., 2007). Notably, early after HIV-1 infection of huNOG mice no 
viremia could be detected, and a detectable viral load was only observed late after infection 
using high doses of R5-tropic or X4-tropic HIV-1. No significant decline in the CD4/CD8 
ratio was observed after R5-tropic virus infection of huNOG mice (Watanabe et al., 2007). 
Conversely, the HIS BALB-Rag/ mice infected with a high dose R5-tropic HIV-1 did 
develop an inversion of the CD4/CD8 T-cell ratio in peripheral blood (Berges et al., 2006; 
Gorantla et al., 2007). After X4-tropic virus infection of huNOG mice a CD4+ cell decline was 
detected at later time points (Watanabe et al., 2007). These findings suggest that humanized 
mice are less susceptible to low dose infection and undergo a slow course of CD4 T-cell 
depletion as compared to HIV-1 infected individuals. In addition, immune responses to 
HIV-1 infection in HIS mice generated from newborns are suboptimal resulting in only poor 
development of virus-specific antibodies and absence of HIV-specific T cell responses (An et 
al., 2007; Baenziger et al., 2006; Gorantla et al., 2007; Sato et al., 2010).  
A more sophisticated HIS mouse model has been generated using NOD/SCID mice that 
were co-transplantated with human fetal Thy/Liv and CD34+ HSC either from fetal liver 
(Lan et al., 2006; Tonomura et al., 2008) or bone marrow (BLT mice) (Melkus et al., 2006). 
BLT mice mounted stronger antigen-specific T-cell responses and T cell–dependent IgG 
production after in vivo antigen immunization (Melkus et al., 2006; Tonomura et al., 2008). 
Notably, a detectable viral load was observed in BLT mice after low dose infection with R5-
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tropic virus, which was associated with the depletion of human CD4+ T cells in the blood 
(Brainard et al., 2009). Also, it was demonstrated that B cells in BLT mice were able to mount 
robust virus-specific antibody responses, although these responses were delayed as 
compared to adult human HIV infection (Brainard et al., 2009). Besides the intravenous 
route of HIV infection, HIS mice can be infected with HIV by relevant intravaginal and 
intrarectal routes (Berges et al., 2008; Denton et al., 2008; Sun et al., 2007). Taken together, 
this advanced humanized BLT mouse model shows great potential as a model to study HIV 
infection in vivo and holds promise for prospective studies to test the efficacy of candidate 
HIV vaccines and to validate the activity of antimicrobial agents acting at mucosal surfaces. 
11. Summary and conclusion 
Our knowledge of HIV infection of the thymus is primarily derived from animal models 
except for incidental reports of HIV infection in vivo in infants, children and adults (Bandera 
et al., 2010; Brunner et al., 2011; Calabro et al., 1995; Gaulton et al., 1997; Haynes et al., 1999; 
Rosenzweig et al., 1994). Indirect evidence of the impact of antiretroviral therapy on 
recovery of the thymus has been obtained through imaging studies and measurements of 
TRECs (Dion et al., 2007; Halnon et al., 2005; Lee et al., 2006; McCune et al., 1998 and 
reviewed in (Ho Tsong Fang et al., 2005)). It is clear that the thymus plays an important role 
in HIV infection and in the regeneration of naïve CD4+ T cells. Thymocytes, but also minor 
thymocyte subsets are targets for CCR5- and CXCR4-tropic HIV. These subsets include 
CD4+ TCR, TCR and CD161+ cells resembling NK-T cells (Gurney et al., 2002), Treg, 
cDC and pDC. Furthermore, pDC stimulated with HIV produce high levels of IFN- and 
thereby contribute to immune activation in particular when IFN- levels are not controlled. 
Notably, insufficient T cell regeneration may not only be at the level of the thymus, but also 
at the level of hematopoietic stem cells. This is illustrated by the recent finding that the 
function and numbers of CD34+ hematopoietic stem cells in peripheral blood of HIV 
infected individuals are impaired despite control of viral replication (Sauce et al., 2011). 
Also, impaired progenitor cell function of umbilical cord blood CD34+ cells, including 
decreased cloning efficiency and generation of CD4+ T lymphocytes in fetal thymic organ 
culture, was observed in HIV-negative infants born to HIV-positive mothers (Nielsen et al., 
2001). Consistent with these results, failure of hematopoiesis leading to impaired T cell 
regeneration was observed in SIV infected macaques and found to be unrelated to viral 
loads (Thiebot et al., 2005). Finally, a recent observation suggests that CD34+ cells can also be 
infected with HIV (Carter et al., 2010). Collectively, these results imply that HIV in addition 
to thymic destruction can also adversely affect thymic progenitor cells, likely caused by 
immune activation, and thereby contribute to T cell depletion in HIV infected individuals.  
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